Mizokami A - Search Results

1

FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway.

Imamura Y, Sakamoto S, Endo T, Utsumi T, Fuse M, Suyama T, Kawamura K, Imamoto T, Yano K, Uzawa K, Nihei N, Suzuki H, Mizokami A, Ueda T, Seki N, Tanzawa H, Ichikawa T. Imamura Y, et al. Among authors: mizokami a. PLoS One. 2012;7(8):e42456. doi: 10.1371/journal.pone.0042456. Epub 2012 Aug 3. PLoS One. 2012. PMID: 22879989 Free PMC article.

2

Regulation of androgen receptor by androgen and epidermal growth factor in a human prostatic cancer cell line, LNCaP.

Mizokami A, Saiga H, Matsui T, Mita T, Sugita A. Mizokami A, et al. Endocrinol Jpn. 1992 Jun;39(3):235-43. doi: 10.1507/endocrj1954.39.235. Endocrinol Jpn. 1992. PMID: 1425449 Free article.

3

Inhibition of growth and increase of acid phosphatase by testosterone on androgen-independent murine prostatic cancer cells transfected with androgen receptor cDNA.

Suzuki H, Nihei N, Sato N, Ichikawa T, Mizokami A, Shimazaki J. Suzuki H, et al. Among authors: mizokami a. Prostate. 1994 Dec;25(6):310-9. doi: 10.1002/pros.2990250605. Prostate. 1994. PMID: 7997435

4

Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.

Mizokami A, Gotoh A, Yamada H, Keller ET, Matsumoto T. Mizokami A, et al. J Urol. 2000 Sep;164(3 Pt 1):800-5. doi: 10.1097/00005392-200009010-00053. J Urol. 2000. PMID: 10953159

5

Epigenetic regulation of androgen receptor gene expression in human prostate cancers.

Nakayama T, Watanabe M, Suzuki H, Toyota M, Sekita N, Hirokawa Y, Mizokami A, Ito H, Yatani R, Shiraishi T. Nakayama T, et al. Among authors: mizokami a. Lab Invest. 2000 Dec;80(12):1789-96. doi: 10.1038/labinvest.3780190. Lab Invest. 2000. PMID: 11140692 Free article.

6

Long-term exposure of tumor necrosis factor alpha causes hypersensitivity to androgen and anti-androgen withdrawal phenomenon in LNCaP prostate cancer cells.

Harada S, Keller ET, Fujimoto N, Koshida K, Namiki M, Matsumoto T, Mizokami A. Harada S, et al. Among authors: mizokami a. Prostate. 2001 Mar 1;46(4):319-26. doi: 10.1002/1097-0045(20010301)46:4<319::aid-pros1039>3.0.co;2-c. Prostate. 2001. PMID: 11241555

7

Cyclooxygenase-2 promotes prostate cancer progression.

Fujita H, Koshida K, Keller ET, Takahashi Y, Yoshimito T, Namiki M, Mizokami A. Fujita H, et al. Among authors: mizokami a. Prostate. 2002 Nov 1;53(3):232-40. doi: 10.1002/pros.10152. Prostate. 2002. PMID: 12386924

8

[Mechanisms of prostate cancer recurrence].

Mizokami A, Namiki M. Mizokami A, et al. Hinyokika Kiyo. 2002 Nov;48(11):709-11. Hinyokika Kiyo. 2002. PMID: 12512146 Free article. Japanese.

9

Bisphosphonate induces apoptosis and inhibits pro-osteoclastic gene expression in prostate cancer cells.

Asahi H, Mizokami A, Miwa S, Keller ET, Koshida K, Namiki M. Asahi H, et al. Among authors: mizokami a. Int J Urol. 2006 May;13(5):593-600. doi: 10.1111/j.1442-2042.2006.01360.x. Int J Urol. 2006. PMID: 16771731 Free article.

10

Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.

Iwasa Y, Mizokami A, Miwa S, Koshida K, Namiki M. Iwasa Y, et al. Among authors: mizokami a. Int J Urol. 2007 Mar;14(3):233-9. doi: 10.1111/j.1442-2042.2007.01532.x. Int J Urol. 2007. PMID: 17430262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

498 results

Search Page

Filters